Effects of Effera Human Lactoferrin at One Dose Compared to Placebo on Gut Permeability

ClinicalTrials.gov ID: NCT07035964

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07035964. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:15 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double-Blind, Placebo-Controlled, Parallel Study on the Effects of Effera Human Lactoferrin on Gastrointestinal Permeability

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the impact of 28-day supplementation with effera human lactoferrin, compared to a placebo control product on indicators of gut barrier health in males and females

Study identification

NCT ID: NCT07035964
Recruitment status: Recruiting
Study type: Interventional
Phase: Not applicable
Lead sponsor: Helaina Inc.; Industry
Enrollment: 46 participants

Conditions and interventions

Conditions

Interventions

human lactoferrin Dietary Supplement
Placebo Dietary Supplement

Dietary Supplement

Eligibility (public fields only)

Age range: 18 Years to 40 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 4, 2025 (Actual)
Primary completion: Aug 30, 2025 (Estimated)
Completion: Aug 30, 2025 (Estimated)
Last update posted: Jun 25, 2025

2025

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Biofortis Inc	Addison	Illinois	60101	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07035964, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jun 25, 2025 · Synced Nov 15, 2026